4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-17-066820
Chief Financial Officer gave up 775 shares (to pay taxes)
- Chief Financial Officer acquired 2,550 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ruffo Frank Chief Financial Officer | 2017-12-15 | Option exercise | +1,300 | 144,872 | D: show line 1 in the form | ||
| Ruffo Frank Chief Financial Officer | 2017-12-15 | Shares withheld for taxes | −395 | $24.23 | $9,571 | 144,477 | D: show line 2 in the form |
| Ruffo Frank Chief Financial Officer | 2017-12-18 | Option exercise | +1,250 | 145,727 | D: show line 3 in the form | ||
| Ruffo Frank Chief Financial Officer | 2017-12-18 | Shares withheld for taxes | −380 | $24.12 | $9,166 | 145,347 | D: show line 4 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Ruffo Frank Chief Financial Officer | 2017-12-15 | Option exercise · Restricted Stock Units | −1,300 | 9,100 | D: show line 5 in the form | |||||
| Ruffo Frank Chief Financial Officer | 2017-12-18 | Option exercise · Restricted Stock Units | −1,250 | 2,500 | D: show line 6 in the form |
Loading xslF345X03/doc4.xml…